Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efavirenz”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00162097
What this trial is testing

Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment

Who this might be right for
HIV InfectionsHepatic Impairment
Bristol-Myers Squibb 21
Post-approval studies (Phase 4)UnknownNCT02285374
What this trial is testing

Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity

Who this might be right for
HIV
St Stephens Aids Trust 40
Testing effectiveness (Phase 2)Looking for participantsNCT05076682
What this trial is testing

Reverse Triple Negative Immune Resistant Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Fudan University 80
Testing effectiveness (Phase 2)Study completedNCT01286740
What this trial is testing

Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR

Who this might be right for
HIV-1 Infection
Gilead Sciences 50
Early research (Phase 1)Study completedNCT03706885
What this trial is testing

Efavirenz for Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease, Early Onset
Case Western Reserve University 5
Not applicableWithdrawnNCT00023218
What this trial is testing

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT01985399
What this trial is testing

Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")

Who this might be right for
HIVAIDS
Stanford University 100
Testing effectiveness (Phase 2)Study completedNCT00023413
What this trial is testing

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Who this might be right for
HIV InfectionsTuberculosis
Centers for Disease Control and Prevention 20
Large-scale testing (Phase 3)Study completedNCT00369941
What this trial is testing

Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 566
Testing effectiveness (Phase 2)Study completedNCT00002419
What this trial is testing

Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment

Who this might be right for
HIV Infections
Gilead Sciences 25
Testing effectiveness (Phase 2)Study completedNCT01338883
What this trial is testing

Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus

Who this might be right for
HIV-1 Infection
Tobira Therapeutics, Inc. 143
Not applicableStudy completedNCT01322932
What this trial is testing

Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey

Who this might be right for
HIV Infection
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland 95
Post-approval studies (Phase 4)Study completedNCT02042001
What this trial is testing

Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects

Who this might be right for
Impaired CognitionDepression/AnxietyPoor Quality Sleep+2 more
Azienda Ospedaliera San Gerardo di Monza 74
Early research (Phase 1)Study completedNCT00357188
What this trial is testing

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

Who this might be right for
HIV InfectionsProtease Inhibitor
Bristol-Myers Squibb 22
Not applicableStudy completedNCT01180075
What this trial is testing

Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population

Who this might be right for
Human Immunodeficiency Virus
University of North Carolina, Chapel Hill 85
Large-scale testing (Phase 3)Study completedNCT03178084
What this trial is testing

Effects of Maraviroc vs. Efavirenz on CD4/CD8 Ratio

Who this might be right for
HIV/AIDS
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 721
Not applicableStudy completedNCT00734344
What this trial is testing

Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection

Who this might be right for
Acute HIV Infection
University of Alabama at Birmingham 18
Testing effectiveness (Phase 2)Study completedNCT02412436
What this trial is testing

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Who this might be right for
HIV-1 InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 62
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Post-approval studies (Phase 4)Study completedNCT00704249
What this trial is testing

VENICE Study Nevirapine Full Dose/Dose Escalation

Who this might be right for
HIV Infections
Clinical Trial Agency of HIV Study Group 80
Next Page